OXiGENE Announces Presentation at BIO CEO Conference on February 12th

[at noodls] – SOUTH SAN FRANCISCO, Calif., Feb. 4, 2013 (GLOBE NEWSWIRE) — OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter … more

View todays social media effects on OXGN

View the latest stocks trending across Twitter. Click to view dashboard

See who OXiGENE is hiring next, click here to view